Wen Juan Tu - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Molecular Cancer Therapeutics|June 11, 2025

Depleting the action of EZH2 through PI3K-mTOR inhibition to overcome metastasis and immunotherapy resistance in triple-negative breast cancerMichelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann, et al.

Nature Communications|June 27, 2023

In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprintingWen Juan Tu, Michelle Melino, Jenny Dunn, et al.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|June 16, 2021

[Clinical features of preterm infants with a birth weight less than 1 500 g undergoing different intensities of resuscitation: a multicenter retrospective analysis]Miao Qian, Zhang-Bin Yu, Xiao-Hui Chen, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Molecular Cancer Therapeutics|June 11, 2025

Depleting the action of EZH2 through PI3K-mTOR inhibition to overcome metastasis and immunotherapy resistance in triple-negative breast cancerMichelle Melino, Wen Juan Tu, Helle Bielefeldt-Ohmann, et al.

Nature Communications|June 27, 2023

In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprintingWen Juan Tu, Michelle Melino, Jenny Dunn, et al.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|June 16, 2021

[Clinical features of preterm infants with a birth weight less than 1 500 g undergoing different intensities of resuscitation: a multicenter retrospective analysis]Miao Qian, Zhang-Bin Yu, Xiao-Hui Chen, et al.

Pageof 3